TSX Risk Exchange Stock Maintenance Announcement – QNT Press Release

[ad_1]

Vancouver, British Columbia, July 8, 2021 / CNW /-

Toronto Stock Exchange Venture Capital Corporation

AIS Resources Ltd (“AIS“)
Announcement type: CUSIP change
Announcement date: July 8, 2021
TSX Venture Capital Level 2 the company

Valid at the time of opening July 9, 2021, The CUSIP of AIS Resources Limited will be changed from “001430107” to “001431105. The company name has not been changed, the transaction code has not been changed, and the capital has not been consolidated.

_________________________________________

Marvel Biosciences (“MRVL“)
[formerly Alphanco Venture Corp. ("AVC.P")]
Announcement type: resumption of trading, eligible transaction-completion/new symbol, private placement-non-brokerage, name change
Announcement date: July 8, 2021
TSX Venture Capital Level 2 the company

The company’s ordinary shares from the date of suspension October 28, 2020, Pending qualified transaction.

Resume trading

Valid at the time of opening, Monday, July 12, 2021, Marvel Biosciences Corp.’s common stock will begin trading on the TSX Venture Exchange under the new symbol “MRVL”.

Eligible transaction completed/new symbol

TSX Venture Exchange has accepted the submission of eligible transactions from the company described in the filing statement whose date is the submission date March 16, 2021. As a result, at the opening ceremony Monday, July 12, 2021, The company will no longer be considered a capital pool company. Eligible transactions include the following:

Eligible transactions include a fair merger involving Marvel Biotechnology Inc., at a consideration of 19,013,431 shares, at a recognized price 0.40 USD Per share.

The 11,400,098 shares issued to the principal pursuant to a qualifying transaction will comply with the secondary value securities custody agreement that will be terminated within 36 months. In accordance with the exchange’s seed stock resale restrictions, 150,000 shares issued to non-principals under qualifying transactions will be subject to a level 2 value securities custody agreement, which will be lifted within 36 months. The 2,700,000 shares are subject to the CPC custody agreement, which will be terminated within 18 months.

Insider/Professional Group Participation:

Insider = Y/

name

Professional Group=P

Number of shares

J. Roderick Matheson

Yes

5,000,049

Mark Williams

Yes

5,000,049

Jeremy Fair

Yes

600,000

Preston Martin

Yes

400,000

Jacqueline Groot

Yes

400,000

Private Equity-Non-Broker

The TSX Venture Exchange has accepted the submission of documents regarding the announced non-brokered private placement November 3, 2020:

Number of shares:

6,540,000 shares

price:

USD 0.40 per share

Number of Placees:

80 people

Insider/Professional Group Participation:

Insider = Y/

name

Professional Group=P

Number of shares

J. Roderick Matheson

Yes

500,000

Jacqueline Groot

Yes

250,000

Neil Johnson

Yes

125,000

Yan Qiong

Yes

50,000

Convergence of professional group participation

2,080,000 shares

(7 places)

Discoverer’s fee:

$49,120 in cash paid to Leede Jones Gable Inc.

$40,000 in cash paid to Raymond James Ltd.

US$34,080 in cash paid to Canaccord Genuity Corp.

$12,800 in cash paid to iA Private Wealth

US$6,400 in cash paid to Research Capital Corporation

$1,600 in cash paid to Acumen Capital

Name change

According to a resolution passed by the directors June 21, 2021, The company changed its name as follows. There is no capital integration.

Valid at the time of opening, Monday, July 12, 2021, Marvel Biosciences Corp.’s common stock will begin trading on the TSX Venture Exchange, and Alphanco Venture Corp.’s common stock will be delisted.

For more information, please see the company date for March 16, 2021, This was submitted on SEDAR.

The company is classified as a “Research and Development (Physics, Engineering and Life Sciences)” company.

capital:

unlimited

Stocks with no par value, of which

32,586,231

Shares have been issued and circulated

escrow:

14,250,098

share it

Transfer agent:

Odyssey Trust Company

Transaction symbol:

MRVL (new)

CUSIP number:

57384M 10 7 (new)

Company contacts:

Company Secretary Jacqueline Groot

company address:

420, 505 8day Avenue Southwest

Calgary, AB T2P 1G2

work phone:

(403) 770-2467

Company email address:

jackie@marvelbiotechnology.com

_______________________________

Power Nickel Corporation (“PNPN“)
[formerly Chilean Metals Inc. ("CMX")]
Announcement type: name change
Announcement date: July 8, 2021
TSX Venture Capital Level 2 the company

According to a resolution passed by the directors March 15, 2021, The company changed its name as follows: Power Nickel Corporation There is no capital integration.

Effective Monday, July 12, 2021, The common stock of Power Nickel Inc. will begin trading on the TSX Venture Exchange, and the common stock of Chilean Metals will be delisted. The company is classified as a “mining exploration and development” company.

capital:

unlimited

Stocks with no par value, of which

77,786,273

Shares have been issued and circulated

escrow:

zero

share it

Transfer agent:

AST Trust Company (Canada)

Transaction symbol:

PNPN

(new)

CUSIP number:

739301109

(new)

________________________________________

First helium co., ltd. (“Heli“)
Announcement type: newly listed stocks
Announcement date: July 8, 2021
TSX Venture Capital Level 2 the company

Effective at opening Monday, July 12, 2021, The common stock of First Helium Inc. (the “Company”) will begin trading on the TSX Venture Exchange (the “Exchange”). The company is classified as an “oil and gas” and “industrial” company.

Prior to and related to the company’s common stock being listed on the Stock Exchange, the company’s detailed prospectus date was June 28, 2021 (“Prospectus”), has been filed with the exchange and accepted by the exchange, and has been filed with the Securities Commission of British Columbia and received June 28, 2021According to the provisions of the Securities Act of British Columbia, the receipt also proves that the Ontario Securities Commission has issued a receipt for the prospectus.The prospectus is also submitted under Multilateral Instrument 11-102 Passport system (“Instrument”) in Alberta, Saskatchewan, Manitoba with Nova ScotiaIf the conditions of the tool are met, the prospectus receipt is deemed to have been issued by the regulatory authority in each jurisdiction.

After the automatic conversion of the company’s 26,228,286 subscription receipts (each, “subscription receipt”), the prospectus is eligible to allocate a maximum of 35,844,952 ordinary shares in the company’s capital without additional consideration; a maximum of 9,616,666 units of the company’s convertible bonds (each Units are called “convertible bond units”), which can be issued when the issuer’s outstanding principal and accrued interest of the unsecured convertible bonds are automatically converted. 2,800,000 USD (Each, “convertible bond”).The subscription receipt has been March 15, 2021 with March 18, 2021, The price is 0.35 USD Receipt for each subscription.Convertible bonds March 2, 2021, The conversion price is 0.30 USD Each convertible bond unit.

Each subscription receipt includes one common stock and one half of the common stock purchase warrant (for each warrant, one “warrant”).The warrant will give the holder the right to purchase one common share 0.50 USD Each ordinary share shall end two years from the date of listing of the company’s ordinary shares.

Each convertible bond unit will consist of one common share and one warrant.The warrant will give the holder the right to purchase one common share 0.50 USD Each ordinary share shall end two years from the date of listing of the company’s ordinary shares.

Corporate jurisdiction:

British Columbia

capital:

Unlimited ordinary shares with no par value, of which 65,611,370 ordinary shares have been issued and circulated.

Escrow Securities:

9,551,877 ordinary shares and 965,166 ordinary shares warrants are under custody.

Transfer agent:

Computershare Investor Services Company

Transaction symbol:

Join forces

CUSIP number:

32050C105

Sponsoring members:

not any

Agency warrant:

The 1,709,687 warrants will give holders the right to purchase one unit of the company (“broker warrant unit”) at a price of $0.35 each, until the end of two years from the date of listing of the company’s common stock. Each brokerage warrant unit will consist of one common share and one-half of one warrant.

For more information, see the company date for June 28, 2021 And press release date July 8, 2021, Can be found in the company profile on SEDAR.

Company contacts:

Edward Berezniki

company address:

550-800 West Pender Street Vancouver, BC V6C 2V6

work phone:

778-327-5799

Company fax number:

not applicable

Company email address:

ebereznicki@firsthelium.com

________________________________________

GTEC Holdings Limited (“GTEC”) (“GTEC.WT”)
Announcement type: graduation
Announcement date: July 8, 2021
TSX Venture Capital Secondary Company

The TSX Venture Exchange has learned that the company’s stocks and warrants will be listed and Start trading on the Toronto Stock Exchange when the market opens on July 12, 2021, Under the name “Avant Brands Inc.” and the symbols “AVNT” and “AVNT.WT”, respectively.

Due to this graduation, the TSX Venture Exchange will no longer trade under the codes “GTEC” and “GTEC.WT”. July 9, 2021, Its stocks and warrants will be delisted from TSX Venture Exchange when trading on the Toronto Stock Exchange begins.

________________________________________

ITAFOS INC. (“IFOS”)
[formerly Itafos ("IFOS")]
Announcement type: Miscellaneous, renamed
Announcement date: July 8, 2021
TSX Venture Capital Secondary Company

Corporate jurisdiction

The TSX Venture Exchange has accepted the continuation of the submitted company Cayman Islands To Delaware Approved by the company’s shareholders June 4, 2021. The company has notified the Stock Exchange that the change has taken effect July 1, 2021. Information on shareholder rights Delaware, See the management information bulletin of the company’s general meeting of shareholders April 26, 2021.

CUSIP number change

As the company’s jurisdiction changes, The CUSIP number will be changed to 465270106 at the opening. Monday, July 12, 2021.

Name change

In conjunction with the change of the company’s jurisdiction, the company has been renamed as follows: Itafos There is no capital integration.

Valid at the opening, at Monday, July 12, 2021, Itafos Inc.’s common stock will begin trading on the Toronto Stock Exchange’s Growth Enterprise Market, and Itafos’s common stock will be delisted. The company is classified as a “mining” company.

capital:

5,000,000,000

Shares with a par value of $0.00001 per share, of which

186,814,842

Shares have been issued and circulated

escrow:

zero

share it

Transfer agent:

Toronto Stock Exchange Trust Company

Transaction symbol:

FIFA

(constant)

CUSIP number:

465270106

(new)

The full story on Benzinga.com

[ad_2]

Source link